Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
This article was originally published in The Tan Sheet
Executive Summary
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters